Date,Symbol,Headline,Source11/20/20,MRNA-US,IEEE InTech Virtual Forum Unites Global Leaders to Examine Tech Industry's Response to Covid-19,PRN11/17/20,MRNA-US,"US Infectious Disease Physicians Predict a COVID-19 Vaccine by May 2021, According to InCrowd Data ",BW11/17/20,MRNA-US,European Medicines Agency Begins Rolling Review of Moderna's mRNA Vaccine Candidate Against COVID-19 (mRNA-1273),BW11/17/20,MRNA-US,DJ Press Release: European Medicines Agency Begins Rolling Review of Moderna's mRNA Vaccine Candidate Against COVID-19 (mRNA-1273),DJGM11/17/20,MRNA-US,Moderna Announces Supply Agreement with United Kingdom Government to Supply mRNA Vaccine Against COVID-19 (mRNA-1273) if Approved for Use,BW11/17/20,MRNA-US,DJ Press Release: Moderna Announces Supply Agreement -2-,DJGM11/17/20,MRNA-US,DJ Press Release: Moderna Announces Supply Agreement with United Kingdom Government to Supply mRNA Vaccine Against COVID-19 (mRNA-1273) if Approved for Use,DJGM11/17/20,MRNA-US,Diagnostic Testing Remains Vital as New Treatment Breakthroughs are Announced,PRN11/16/20,MRNA-US,Moderna's COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study,BW11/16/20,MRNA-US,DJ Press Release: Moderna's COVID-19 Vaccine -2-,DJGM11/16/20,MRNA-US,DJ Press Release: Moderna's COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study,DJGM11/16/20,MRNA-US,Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures,BW11/16/20,MRNA-US,DJ Press Release: Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures,DJGM11/13/20,MRNA-US,Swissmedic Begins Rolling Review of Moderna's mRNA Vaccine Against COVID-19 (mRNA-1273) ,BW11/13/20,MRNA-US,DJ Press Release: Swissmedic Begins Rolling Review of Moderna's mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM11/11/20,MRNA-US,Moderna Has Completed Case Accrual for First Planned Interim Analysis of its mRNA Vaccine Against COVID-19 (mRNA-1273),BW11/11/20,MRNA-US,DJ Press Release: Moderna Has Completed Case Accrual for First Planned Interim Analysis of its mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM11/11/20,MRNA-US,Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program,BW11/11/20,MRNA-US,DJ Press Release: Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program,DJGM11/2/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Jefferies Healthcare Conference for 18-November-2020 11:25 AM ET",FCSTEV11/2/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Credit Suisse Healthcare Conference for 11-November-2020 8:00 AM ET",FCSTEV11/2/20,MRNA-US,Moderna to Present at Upcoming Investor Conferences in November 2020,BW11/2/20,MRNA-US,DJ Press Release: Moderna to Present at Upcoming Investor Conferences in November 2020,DJGM10/30/20,MRNA-US,Moderna Named Top Employer by Science for Sixth Consecutive Year,BW10/30/20,MRNA-US,DJ Press Release: Moderna Named Top Employer by Science for Sixth Consecutive Year,DJGM10/29/20,MRNA-US,Takeda élargit ses réserves de vaccins contre la COVID-19 au Japon grâce à un partenariat avec Moderna et le gouvernement japonais ,BW10/29/20,MRNA-US,Takeda erweitert Kapazitäten zur COVID-19-Impfstoffversorgung in Japan durch Partnerschaft mit Moderna und japanischer Regierung ,BW10/29/20,MRNA-US,DJ Press Release: Moderna Reports Third Quarter 2020 -4-,DJGM10/29/20,MRNA-US,DJ Press Release: Moderna Reports Third Quarter 2020 Financial Results and Provides Business Updates,DJGM10/29/20,MRNA-US,DJ Press Release: Moderna Reports Third Quarter 2020 -2-,DJGM10/29/20,MRNA-US,DJ Press Release: Moderna Reports Third Quarter 2020 -3-,DJGM10/29/20,MRNA-US,"Moderna Reports Third Quarter 2020 Financial Results and Provides Business Updates",BW10/29/20,MRNA-US,"Moderna, Inc. to Host Earnings Call",NEWS_ACW10/28/20,MRNA-US,DJ Press Release: Moderna Partners with Takeda and the Government of Japan to Supply 50 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273) to Japan,DJGM10/28/20,MRNA-US,DJ Press Release: Takeda Expands COVID-19 Vaccine Supply in Japan Through Partnership with Moderna and Government of Japan,DJGM10/28/20,MRNA-US,Moderna Partners with Takeda and the Government of Japan to Supply 50 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273) to Japan,BW10/27/20,MRNA-US,DJ Press Release: UK Medicines and Healthcare products Regulatory Agency Begins Rolling Review of Moderna's mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM10/27/20,MRNA-US,UK Medicines and Healthcare products Regulatory Agency Begins Rolling Review of Moderna's mRNA Vaccine Against COVID-19 (mRNA-1273) ,BW10/26/20,MRNA-US,DJ Press Release: Moderna Announces Supply Agreement with the Ministry of Public Health to Supply Qatar with mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM10/26/20,MRNA-US,Moderna Announces Supply Agreement with the Ministry of Public Health to Supply Qatar with mRNA Vaccine Against COVID-19 (mRNA-1273) ,BW10/22/20,MRNA-US,DJ Press Release: Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM10/22/20,MRNA-US,Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273),BW10/19/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Gabelli Funds - Columbia Business School Healthcare Symposium for 13-November-2020 9:10 AM ET",FCSTEV10/15/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q3 2020 Earnings Call for 29-October-2020 8:00 AM ET",FCSTEV10/15/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q3 2020 Earnings Release for 29-October-2020 7:00 AM ET",FCSTEV10/15/20,MRNA-US,"DJ Press Release: Moderna to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020",DJGM10/15/20,MRNA-US,"Moderna to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020",BW10/14/20,MRNA-US,DJ Press Release: Moderna Receives Confirmation of -2-,DJGM10/14/20,MRNA-US,DJ Press Release: Moderna Receives Confirmation of Eligibility for Submission of Marketing Authorization Application to the European Medicines Agency for mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM10/14/20,MRNA-US,Moderna Receives Confirmation of Eligibility for Submission of Marketing Authorization Application to the European Medicines Agency for mRNA Vaccine Against COVID-19 (mRNA-1273),BW10/13/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules BioNJ C-Suite Summit for 30-October-2020",FCSTEV10/13/20,MRNA-US,Moderna Announces Initiation of Rolling Submission to Health Canada for mRNA Vaccine Against COVID-19 (mRNA-1273),BW10/13/20,MRNA-US,DJ Press Release: Moderna Announces Initiation of -2-,DJGM10/13/20,MRNA-US,DJ Press Release: Moderna Announces Initiation of Rolling Submission to Health Canada for mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM10/8/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Business Update Call for 8-October-2020 8:00 AM ET",FCSTEV10/8/20,MRNA-US,"DARPA Awards Moderna up to $56 Million to Enable Small-Scale, Rapid Mobile Manufacturing of Nucleic Acid Vaccines and Therapeutics",BW10/8/20,MRNA-US,"DJ Press Release: DARPA Awards Moderna up to $56 Million to Enable Small-Scale, Rapid Mobile Manufacturing of Nucleic Acid Vaccines and Therapeutics",DJGM10/8/20,MRNA-US,Moderna Announces Updates on Respiratory Syncytial Virus (RSV) Vaccine Program,BW10/8/20,MRNA-US,DJ Press Release: Moderna Announces Updates on Respiratory Syncytial Virus (RSV) Vaccine Program,DJGM10/8/20,MRNA-US,DJ Press Release: Moderna Announces Updates on -2-,DJGM10/2/20,MRNA-US,"Thinking about trading options or stock in Moderna, Twilio, Johnson & Johnson, General Electric, or Carnival Corp?",PRN9/29/20,MRNA-US,Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Older Adult Age Cohorts in Phase 1 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273),BW9/29/20,MRNA-US,DJ Press Release: Moderna Announces Publication in -2-,DJGM9/29/20,MRNA-US,DJ Press Release: Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Older Adult Age Cohorts in Phase 1 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM9/28/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Chardan Genetic Medicines Conference for 5-October-2020 2:00 PM ET",FCSTEV9/28/20,MRNA-US,DJ Press Release: Moderna to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference,DJGM9/28/20,MRNA-US,Moderna to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference,BW9/25/20,MRNA-US,EuropeFX Adds Pharma Stocks To Asset List,PRN9/22/20,MRNA-US,Canada Exercises Increased Option for 20 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273),BW9/22/20,MRNA-US,DJ Press Release: Canada Exercises Increased Option for 20 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM9/18/20,MRNA-US,Moderna e Grupo Chiesi firmam acordo para desenvolver tratamento de Hipertensão Arterial Pulmonar (HAP),PRNL9/17/20,MRNA-US,Moderna Announces Progress Across Broad Portfolio and all Three Clinical Stage Therapeutic Areas at 2020 R&D Day,BW9/17/20,MRNA-US,DJ Press Release: Moderna Announces Progress Across -3-,DJGM9/17/20,MRNA-US,DJ Press Release: Moderna Announces Progress Across Broad Portfolio and all Three Clinical Stage Therapeutic Areas at 2020 R&D Day,DJGM9/17/20,MRNA-US,DJ Press Release: Moderna Announces Progress Across -2-,DJGM9/16/20,MRNA-US,Moderna and Vertex Establish New Collaboration to Treat Cystic Fibrosis Using Gene Editing,BW9/16/20,MRNA-US,Moderna and Chiesi Group Establish Collaboration to Discover and Develop mRNA Therapeutics for Pulmonary Arterial Hypertension (PAH),BW9/16/20,MRNA-US,DJ Press Release: Moderna and Chiesi Group Establish Collaboration to Discover and Develop mRNA Therapeutics for Pulmonary Arterial Hypertension (PAH),DJGM9/16/20,MRNA-US,Moderna Announces First Commercial Organization Outside North America in Switzerland,BW9/16/20,MRNA-US,DJ Press Release: Moderna Announces First Commercial Organization Outside North America in Switzerland,DJGM9/10/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Bank of America Merrill Lynch Global Healthcare Conference for 18-September-2020 10:05 AM ET",FCSTEV9/10/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Morgan Stanley Global Healthcare Conference for 14-September-2020 9:45 AM ET",FCSTEV9/10/20,MRNA-US,DJ Press Release: Moderna Names Michael Mullette as Managing Director of New Canadian Subsidiary,DJGM9/10/20,MRNA-US,Moderna Names Michael Mullette as Managing Director of New Canadian Subsidiary,BW9/9/20,MRNA-US,DJ Press Release: Moderna to Present at Upcoming Investor Conferences in September 2020,DJGM9/9/20,MRNA-US,Moderna to Present at Upcoming Investor Conferences in September 2020,BW9/8/20,MRNA-US,Biopharma Leaders Unite to Stand With Science,BW9/8/20,MRNA-US,DJ Press Release: Biopharma Leaders Unite to Stand -2-,DJGM9/8/20,MRNA-US,DJ Press Release: Biopharma Leaders Unite to Stand -3-,DJGM9/8/20,MRNA-US,DJ Press Release: Biopharma Leaders Unite to Stand with Science,DJGM9/8/20,MRNA-US,DJ Press Release: Biopharma Leaders Unite To Stand -3-,DJGM9/8/20,MRNA-US,DJ Press Release: Biopharma Leaders Unite To Stand -2-,DJGM9/8/20,MRNA-US,DJ Press Release: Biopharma Leaders Unite To Stand With Science,DJGM9/8/20,MRNA-US,Biopharma Leaders Unite To Stand With Science,BW9/8/20,MRNA-US,Biopharma Leaders Unite to Stand with Science,BW9/3/20,MRNA-US,"DJ Press Release: Moderna to Host Virtual R&D Day on September 17, 2020",DJGM9/3/20,MRNA-US,"Moderna to Host Virtual R&D Day on September 17, 2020",BW9/1/20,MRNA-US,Testing is in High Demand as Spread of Infection Remains,PRN8/28/20,MRNA-US,"Moderna Confirms Discussions with the Ministry of Health, Labour and Welfare to Supply Japan with 40 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)",BW8/28/20,MRNA-US,"DJ Press Release: Moderna Confirms Discussions with the Ministry of Health, Labour and Welfare to Supply Japan with 40 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)",DJGM8/26/20,MRNA-US,Moderna to Present New Interim Clinical Data About mRNA Vaccine Against COVID-19 (mRNA-1273) at Advisory Committee on Immunization Practices (ACIP) Meeting,BW8/26/20,MRNA-US,DJ Press Release: Moderna to Present New Interim Clinical Data About mRNA Vaccine Against COVID-19 (mRNA-1273) at Advisory Committee on Immunization Practices (ACIP) Meeting,DJGM8/24/20,MRNA-US,Moderna Confirms Advanced Discussions with European Commission to Supply Europe with 80 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273),BW8/24/20,MRNA-US,DJ Press Release: Moderna Confirms Advanced -2-,DJGM8/24/20,MRNA-US,DJ Press Release: Moderna Confirms Advanced Discussions with European Commission to Supply Europe with 80 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM8/19/20,MRNA-US,Innovative Medical Devices Help Healthcare Systems Become More Efficient,PRN8/11/20,MRNA-US,Moderna Announces Supply Agreement with U.S. Government for Initial 100 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273),BW8/11/20,MRNA-US,DJ Press Release: Moderna Announces Supply Agreement -2-,DJGM8/11/20,MRNA-US,DJ Press Release: Moderna Announces Supply Agreement with U.S. Government for Initial 100 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM8/10/20,MRNA-US,"DJ Press Release: John Lepore Joins Moderna as Senior Vice President, Government Engagement",DJGM8/10/20,MRNA-US,"John Lepore Joins Moderna as Senior Vice President, Government Engagement",BW8/5/20,MRNA-US,DJ Press Release: AWS Powers Moderna's Digital Biotechnology Platform to Develop New Class of Vaccines and Therapeutics,DJGM8/5/20,MRNA-US,AWS Powers Moderna's Digital Biotechnology Platform to Develop New Class of Vaccines and Therapeutics,BW8/5/20,MRNA-US,DJ Press Release: Moderna Reports Second Quarter -2-,DJGM8/5/20,MRNA-US,DJ Press Release: Moderna Reports Second Quarter -3-,DJGM8/5/20,MRNA-US,DJ Press Release: Moderna Reports Second Quarter 2020 Financial Results and Provides Business Updates,DJGM8/5/20,MRNA-US,DJ Press Release: Moderna Reports Second Quarter -4-,DJGM8/5/20,MRNA-US,Moderna Reports Second Quarter 2020 Financial Results and Provides Business Updates,BW7/30/20,MRNA-US,DJ Press Release: CORRECTING AND REPLACING: Moderna Announces Resignation of Dr. Elizabeth Nabel From Board of Directors,DJGM7/30/20,MRNA-US,Moderna Announces Resignation of Dr. Elizabeth Nabel From Board of Directors,BW7/30/20,MRNA-US,"Thinking about buying stock in MobileIron Inc, Waitr Holdings, Electrameccanica Vehicles, Boeing, or Moderna Inc?",PRN7/28/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules mRNA-1273 Vaccine Update Call for 29-July-2020 8:00 AM ET",FCSTEV7/28/20,MRNA-US,Moderna Announces Publication in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of its mRNA Vaccine Against COVID-19 (mRNA-1273),BW7/28/20,MRNA-US,DJ Press Release: Moderna Announces Publication in -2-,DJGM7/28/20,MRNA-US,DJ Press Release: Moderna Announces Publication in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of its mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM7/27/20,MRNA-US,Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins,BW7/27/20,MRNA-US,DJ Press Release: Moderna Announces Phase 3 COVE -2-,DJGM7/27/20,MRNA-US,DJ Press Release: Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins,DJGM7/26/20,MRNA-US,Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program for Vaccine (mRNA-1273) Against COVID-19,BW7/26/20,MRNA-US,DJ Press Release: Moderna Announces Expansion of -2-,DJGM7/26/20,MRNA-US,DJ Press Release: Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program for Vaccine (mRNA-1273) Against COVID-19,DJGM7/24/20,MRNA-US,Statement from Moderna on Patent Trial and Appeal Board (PTAB) Ruling,BW7/24/20,MRNA-US,DJ Press Release: Statement from Moderna on Patent Trial and Appeal Board (PTAB) Ruling,DJGM7/23/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q2 2020 Earnings Release for 5-August-2020 7:00 AM ET",FCSTEV7/22/20,MRNA-US,DJ Press Release: Medidata Supports Moderna's COVID-19 Vaccine Clinical Trials with Rave Clinical Cloud Platform,DJGM7/22/20,MRNA-US,Medidata Supports Moderna's COVID-19 Vaccine Clinical Trials with Rave Clinical Cloud Platform,BW7/22/20,MRNA-US,DJ Press Release: Dassault Systèmes: Medidata Supports Moderna's COVID-19 Vaccine Clinical Trials with Rave Clinical Cloud Platform,DJGM7/22/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q2 2020 Earnings Call for 5-August-2020 8:00 AM ET",FCSTEV7/22/20,MRNA-US,"DJ Press Release: Moderna to Report Second Quarter 2020 Financial Results on Wednesday, August 5, 2020",DJGM7/22/20,MRNA-US,"Moderna to Report Second Quarter 2020 Financial Results on Wednesday, August 5, 2020",BW7/16/20,MRNA-US,Headlands Research Sites Chosen for Crucial COVID-19 Vaccine Trials,PMZ7/15/20,MRNA-US,Distancing Measures Force Innovations in Patient Monitoring Procedures,PRN7/14/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules mRNA-1273 Phase 1 Study Results Call for 15-July-2020 8:00 AM ET",FCSTEV7/14/20,MRNA-US,Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273),BW7/14/20,MRNA-US,DJ Press Release: Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM7/14/20,MRNA-US,DJ Press Release: Moderna Announces Publication in -2-,DJGM7/14/20,MRNA-US,DJ Press Release: Moderna Announces Publication in -3-,DJGM7/14/20,MRNA-US,"Thinking about trading options or stock in Overstock.com, Moderna, Alibaba, Boeing, or Ford?",PRN7/14/20,MRNA-US,"Moderna to Join the NASDAQ-100 Index Beginning July 20, 2020",BW7/14/20,MRNA-US,"DJ Press Release: Moderna to Join the NASDAQ-100 Index Beginning July 20, 2020",DJGM7/13/20,MRNA-US,"Moderna, Inc. to Join the NASDAQ-100 Index Beginning July 20, 2020",PMZ7/13/20,MRNA-US,"DJ Press Release: Moderna, Inc. to Join the NASDAQ-100 Index Beginning July 20, 2020",DJGM7/9/20,MRNA-US,DJ Press Release: Moderna and ROVI Announce -2-,DJGM7/9/20,MRNA-US,DJ Press Release: Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine Candidate,DJGM7/9/20,MRNA-US,Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine Candidate,BW7/8/20,MRNA-US,DJ Press Release: Moderna Completes Enrollment of -2-,DJGM7/8/20,MRNA-US,DJ Press Release: Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273),DJGM7/8/20,MRNA-US,Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273),BW7/7/20,MRNA-US,DJ Press Release: Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing,DJGM7/7/20,MRNA-US,Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing,PRN7/7/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Sachs Novel Coronavirus Investment Forum - Panel for 8-July-2020 9:00 AM ET",FCSTEV7/3/20,MRNA-US," SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA",PMZ7/1/20,MRNA-US,DJ Press Release: Elizabeth Tallett Joins Moderna's Board of Directors,DJGM7/1/20,MRNA-US,Elizabeth Tallett Joins Moderna's Board of Directors,BW6/25/20,MRNA-US,DJ Press Release: Moderna and Catalent Announce -2-,DJGM6/25/20,MRNA-US,DJ Press Release: Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine Candidate,DJGM6/25/20,MRNA-US,Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine Candidate,BW6/22/20,MRNA-US,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA",PMZ6/18/20,MRNA-US,Are Antivirals For COVID-19 More Likely to Be Developed and Approved Before a Vaccine,PRN6/17/20,MRNA-US,Race For Vaccine Intensifies As COVID-19 Second Wave of Outbreaks Threatens,PRN6/16/20,MRNA-US,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA",PMZ6/16/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules BMO Capital Markets Prescription for Success Healthcare Conference for 23-June-2020 3:00 PM ET",FCSTEV6/16/20,MRNA-US,DJ Press Release: Moderna to Present at BMO 2020 Prescriptions for Success Healthcare Conference,DJGM6/16/20,MRNA-US,Moderna to Present at BMO 2020 Prescriptions for Success Healthcare Conference,BW6/15/20,MRNA-US,"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Moderna, Inc. (MRNA) Investors of Ongoing Investigation into Possible Securities Fraud and Insider Trading, Encourages Investors with Significant Losses to Contact Firm",PMZ6/15/20,MRNA-US,DJ Press Release: Ray Jordan Joins Moderna as Chief Corporate Affairs Officer,DJGM6/15/20,MRNA-US,Ray Jordan Joins Moderna as Chief Corporate Affairs Officer,BW6/12/20,MRNA-US,"MODERNA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA",PMZ6/11/20,MRNA-US,Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19,BW6/11/20,MRNA-US,DJ Press Release: Moderna Advances Late-Stage -2-,DJGM6/11/20,MRNA-US,DJ Press Release: Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19,DJGM6/8/20,MRNA-US,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA",PMZ6/8/20,MRNA-US,Groundbreaking Designs Expand Remote Patient Monitoring Capabilities,PRN6/5/20,MRNA-US,"MODERNA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA",PMZ6/4/20,MRNA-US,DJ Press Release: David Meline Joins Moderna as Chief Financial Officer,DJGM6/4/20,MRNA-US,David Meline Joins Moderna as Chief Financial Officer,BW6/3/20,MRNA-US,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA",PMZ6/2/20,MRNA-US,"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Announces Investigation into Moderna, Inc. (MRNA) for Possible Securities Fraud and Insider Trading, Encourages Investors with Significant Losses to Contact Firm",PMZ6/2/20,MRNA-US,"MRNA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Moderna, Inc. Investigation and Encourages Investors to Contact the Firm",PRN6/2/20,MRNA-US,Moderna Highlights Advances in Platform Science and Innovative Vaccine Research at Third Annual Science Day,BW6/2/20,MRNA-US,DJ Press Release: Moderna Highlights Advances in -2-,DJGM6/2/20,MRNA-US,DJ Press Release: Moderna Highlights Advances in Platform Science and Innovative Vaccine Research at Third Annual Science Day,DJGM6/1/20,MRNA-US,"MODERNA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA",PMZ6/1/20,MRNA-US,"DJ Press Release: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Possible Securities Fraud and Insider Trading, Encourages Moderna, Inc. (MRNA) Investors with Significant Losses to Contact Firm",DJGM6/1/20,MRNA-US,"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Possible Securities Fraud and Insider Trading, Encourages Moderna, Inc. (MRNA) Investors with Significant Losses to Contact Firm",PRN5/29/20,MRNA-US,Moderna Announces First Participants in Each Age Cohort Dosed in Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus,BW5/29/20,MRNA-US,DJ Press Release: Moderna Announces First Participants in Each Age Cohort Dosed in Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus,DJGM5/28/20,MRNA-US,CordenPharma y Moderna colaboran en la obtención de la vacuna contra el coronavirus,PRNE5/28/20,MRNA-US,"CordenPharma und Moderna erweitern strategische Fertigungsvereinbarung, um Lipidhilfsstoffe für Modernas Impfstoff (mRNA-1273) gegen das neuartige Coronavirus SARS-CoV-2 bereitzustellen",PRNE5/28/20,MRNA-US,DJ Press Release: Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity,DJGM5/28/20,MRNA-US,CordenPharma et Moderna étendent leur accord stratégique de services de fabrication pour la fourniture d'excipients lipidiques destinés à être utilisés dans le vaccin de Moderna (ARNm-1273) contre le nouveau coronavirus SRAS-CoV-2,PRNE5/27/20,MRNA-US,DJ Press Release: CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna's Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2,DJGM5/27/20,MRNA-US,CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna's Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2,PRN5/27/20,MRNA-US,"MODERNA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA",PMZ5/27/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Jefferies Virtual Healthcare Conference for 3-June-2020 10:30 AM ET",FCSTEV5/27/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Goldman Sachs Global Healthcare Conference for 11-June-2020 2:10 PM ET",FCSTEV5/27/20,MRNA-US,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA",PMZ5/27/20,MRNA-US,DJ Press Release: Moderna to Present at Upcoming Investor Conferences,DJGM5/27/20,MRNA-US,Moderna to Present at Upcoming Investor Conferences,BW5/26/20,MRNA-US,"MODERNA ALERT: Bragar Eagel & Squire, P.C. is Investigating Moderna, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm",BW5/26/20,MRNA-US,"DJ Press Release: Moderna to Host Virtual Science Day on June 2, 2020",DJGM5/26/20,MRNA-US,"Moderna to Host Virtual Science Day on June 2, 2020",BW5/22/20,MRNA-US,"DJ Press Release: MODERNA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA",DJGM5/22/20,MRNA-US,"MODERNA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA",PRN5/18/20,MRNA-US,Moderna Announces Pricing of Public Offering of Shares of Common Stock,BW5/18/20,MRNA-US,DJ Press Release: Moderna Announces Pricing of Public Offering of Shares of Common Stock,DJGM5/18/20,MRNA-US,Moderna Announces Proposed Public Offering of Shares of Common Stock,BW5/18/20,MRNA-US,DJ Press Release: Moderna Announces Proposed Public Offering of Shares of Common Stock,DJGM5/18/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules mRNA-1273 Interim Phase 1 Data Results Call for 18-May-2020 8:30 AM ET",FCSTEV5/18/20,MRNA-US,DJ Press Release: Moderna Announces Positive Interim -2-,DJGM5/18/20,MRNA-US,DJ Press Release: Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus,DJGM5/18/20,MRNA-US,Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus,BW5/15/20,MRNA-US,Moderna Congratulates Dr. Moncef Slaoui on His Appointment to Oversee the White House's Operation Warp Speed Initiative,BW5/15/20,MRNA-US,DJ Press Release: Moderna Congratulates Dr. Moncef Slaoui on His Appointment to Oversee the White House's Operation Warp Speed Initiative,DJGM5/13/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules UBS Global Virtual Healthcare Conference for 18-May-2020 1:20 PM ET",FCSTEV5/12/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Bank of America Merrill Lynch Virtual Healthcare Conference for 12-May-2020 2:20 PM ET",FCSTEV5/12/20,MRNA-US,DJ Press Release: Moderna Receives FDA Fast Track Designation for mRNA Vaccine (mRNA-1273) Against Novel Coronavirus,DJGM5/12/20,MRNA-US,Moderna Receives FDA Fast Track Designation for mRNA Vaccine (mRNA-1273) Against Novel Coronavirus,BW5/8/20,MRNA-US,DJ Press Release: Moderna to Present at Upcoming Investor Conferences,DJGM5/8/20,MRNA-US,Moderna to Present at Upcoming Investor Conferences,BW5/7/20,MRNA-US,DJ Press Release: Moderna Reports First Quarter 2020 Financial Results and Provides Business Updates,DJGM5/7/20,MRNA-US,DJ Press Release: Moderna Reports First Quarter 2020 -2-,DJGM5/7/20,MRNA-US,DJ Press Release: Moderna Reports First Quarter 2020 -3-,DJGM5/7/20,MRNA-US,DJ Press Release: Moderna Reports First Quarter 2020 -4-,DJGM5/7/20,MRNA-US,Moderna Reports First Quarter 2020 Financial Results and Provides Business Updates,BW4/30/20,MRNA-US,Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna's Vaccine (mRNA-1273) Against Novel Coronavirus,BW4/30/20,MRNA-US,DJ Press Release: Moderna and Lonza Announce -2-,DJGM4/30/20,MRNA-US,DJ Press Release: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna's Vaccine (mRNA-1273) Against Novel Coronavirus,DJGM4/27/20,MRNA-US,DJ Press Release: Moderna Announces IND Submitted to -2-,DJGM4/27/20,MRNA-US,DJ Press Release: Moderna Announces IND Submitted to U.S. FDA for Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus,DJGM4/27/20,MRNA-US,Moderna Announces IND Submitted to U.S. FDA for Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus ,BW4/24/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q1 2020 Earnings Call for 7-May-2020 8:00 AM ET",FCSTEV4/24/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q1 2020 Earnings Release for 7-May-2020 7:00 AM ET",FCSTEV4/23/20,MRNA-US,"Moderna to Report First Quarter 2020 Financial Results on Thursday, May 7th, 2020",BW4/16/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules mRNA-1273 Update Call for 17-April-2020 8:00 AM ET",FCSTEV4/16/20,MRNA-US,Moderna Announces Award from U.S. Government Agency BARDA for up to $483 Million to Accelerate Development of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus ,BW4/16/20,MRNA-US,DJ Press Release: Moderna Announces Award from U.S. -2-,DJGM4/16/20,MRNA-US,DJ Press Release: Moderna Announces Award from U.S. Government Agency BARDA for up to $483 Million to Accelerate Development of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus,DJGM4/15/20,MRNA-US,DJ Press Release: Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response,DJGM4/15/20,MRNA-US,Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response,PRN4/14/20,MRNA-US,DJ Press Release: Moderna Highlights Opportunity of -2-,DJGM4/14/20,MRNA-US,DJ Press Release: Moderna Highlights Opportunity of mRNA Vaccines at its First Vaccines Day,DJGM4/14/20,MRNA-US,Moderna Highlights Opportunity of mRNA Vaccines at its First Vaccines Day ,BW4/10/20,MRNA-US,Moderna Announces that Its 2020 Annual Meeting of Stockholders Will be Held in Virtual Format,BW4/10/20,MRNA-US,DJ Press Release: Moderna Announces that Its 2020 Annual Meeting of Stockholders Will be Held in Virtual Format,DJGM4/8/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Needham Virtual Healthcare Conference for 15-April-2020 10:40 AM ET",FCSTEV4/8/20,MRNA-US,Moderna to Present at 19th Annual Needham Healthcare Conference,BW4/7/20,MRNA-US,DJ Press Release: FDA Accelerates Development of -2-,DJGM4/7/20,MRNA-US,DJ Press Release: FDA Accelerates Development of Novel Therapies for COVID-19,DJGM4/7/20,MRNA-US,"DJ Press Release: Moderna to Host Virtual Vaccines Day on April 14, 2020",DJGM4/7/20,MRNA-US,"Moderna to Host Virtual Vaccines Day on April 14, 2020",BW4/1/20,MRNA-US,"Thinking about buying stock in Advanced Micro Devices, Aytu Bioscience, Inseego, Moderna, or SuperCom?",PRN3/30/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Business Update Call for 30-March-2020 8:00 AM ET",FCSTEV3/29/20,MRNA-US,Moderna Provides Update on the Impact of COVID-19 on Business Operations and Clinical Program Development,BW3/29/20,MRNA-US,DJ Press Release: Moderna Provides Update on the -2-,DJGM3/29/20,MRNA-US,DJ Press Release: Moderna Provides Update on the Impact of COVID-19 on Business Operations and Clinical Program Development,DJGM3/25/20,MRNA-US,DJ Press Release: Moderna to Present at MIT Lecture Series,DJGM3/25/20,MRNA-US,Moderna to Present at MIT Lecture Series,BW3/17/20,MRNA-US,Coronavirus Puts Drug Repurposing on the Fast Track,PRNE3/17/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Annual General Meeting for 29-April-2020 8:00 AM ET",FCSTEV3/16/20,MRNA-US,Moderna Announces First Participant Dosed in NIH-led Phase 1 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus,BW3/16/20,MRNA-US,DJ Press Release: Moderna Announces First Participant Dosed in NIH-led Phase 1 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus,DJGM3/16/20,MRNA-US,DJ Press Release: Moderna Announces First -2-,DJGM3/3/20,MRNA-US,Moderna Completes Enrollment of Cytomegalovirus (CMV) Vaccine (mRNA-1647) Phase 2 Study,BW3/3/20,MRNA-US,DJ Press Release: Moderna Completes Enrollment of -2-,DJGM3/3/20,MRNA-US,DJ Press Release: Moderna Completes Enrollment of Cytomegalovirus (CMV) Vaccine (mRNA-1647) Phase 2 Study,DJGM3/3/20,MRNA-US,Aggressive Infectious Diseases Prompt the Development of Powerful New Blood Tests,PRN3/2/20,MRNA-US,Moderna Announces Updated Plans for its March 4 Manufacturing & Digital Day Event,BW3/2/20,MRNA-US,DJ Press Release: Moderna Announces Updated Plans for its March 4 Manufacturing & Digital Day Event,DJGM2/27/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Analysts and Investor Meeting - Manufacturing & Digital Day for 4-March-2020 1:00 PM ET",FCSTEV2/26/20,MRNA-US,"DJ Press Release: Moderna to Host Manufacturing & Digital Day on March 4, 2020",DJGM2/26/20,MRNA-US,"Moderna to Host Manufacturing & Digital Day on March 4, 2020",BW2/26/20,MRNA-US,Moderna Reports 2019 Fourth Quarter and Full Year Financial Results and Highlights Advancements in Core Modalities,BW2/26/20,MRNA-US,DJ Press Release: Moderna Reports 2019 Fourth Quarter and Full Year Financial Results and Highlights Advancements in Core Modalities,DJGM2/26/20,MRNA-US,DJ Press Release: Moderna Reports 2019 Fourth -4-,DJGM2/26/20,MRNA-US,DJ Press Release: Moderna Reports 2019 Fourth -2-,DJGM2/26/20,MRNA-US,DJ Press Release: Moderna Reports 2019 Fourth -3-,DJGM2/24/20,MRNA-US,Moderna Ships mRNA Vaccine Against Novel Coronavirus (mRNA-1273) for Phase 1 Study,BW2/24/20,MRNA-US,DJ Press Release: Moderna Ships mRNA Vaccine Against Novel Coronavirus (mRNA-1273) for Phase 1 Study,DJGM2/24/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Oppenheimer Healthcare Conference for 17-March-2020 11:30 AM ET",FCSTEV2/24/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Barclays Virtual Global Healthcare Conference for 11-March-2020 9:30 AM ET",FCSTEV2/24/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Cowen Health Care Conference for 3-March-2020 11:20 AM ET",FCSTEV2/24/20,MRNA-US,DJ Press Release: Moderna to Present at Upcoming Investor Conferences,DJGM2/24/20,MRNA-US,Moderna to Present at Upcoming Investor Conferences,BW2/12/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q4 2019 Earnings Call for 26-February-2020 8:00 AM ET",FCSTEV2/12/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q4 2019 Earnings Release for 26-February-2020 7:00 AM ET",FCSTEV2/12/20,MRNA-US,"DJ Press Release: Moderna to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26th, 2020",DJGM2/12/20,MRNA-US,"Moderna to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26th, 2020",BW2/11/20,MRNA-US,Moderna Announces Pricing of Public Offering of Shares of Common Stock,BW2/11/20,MRNA-US,DJ Press Release: Moderna Announces Pricing of Public Offering of Shares of Common Stock,DJGM2/10/20,MRNA-US,Moderna Announces Progress in Prophylactic Vaccines Modality with CMV Vaccine Phase 2 Study Data Now Expected in Third Quarter 2020 and Expands Investment in This Core Modality with Three New Development Candidates,BW2/10/20,MRNA-US,DJ Press Release: Moderna Announces Progress in -2-,DJGM2/10/20,MRNA-US,DJ Press Release: Moderna Announces Progress in Prophylactic Vaccines Modality with CMV Vaccine Phase 2 Study Data Now Expected in Third Quarter 2020 and Expands Investment in This Core Modality with Three New Development Candidates,DJGM2/10/20,MRNA-US,Moderna Announces First Patient Enrolled in Phase 1/2 Study of mRNA-3704 for Methylmalonic Acidemia,BW2/10/20,MRNA-US,DJ Press Release: Moderna Announces First Patient Enrolled in Phase 1/2 Study of mRNA-3704 for Methylmalonic Acidemia,DJGM2/10/20,MRNA-US,Moderna Announces Proposed Public Offering of Shares of Common Stock,BW2/10/20,MRNA-US,DJ Press Release: Moderna Announces Proposed Public Offering of Shares of Common Stock,DJGM2/3/20,MRNA-US,"DJ Press Release: Sandra Horning, M.D. To Join Moderna's Board of Directors",DJGM2/3/20,MRNA-US,"Sandra Horning, M.D. To Join Moderna's Board of Directors",BW1/30/20,MRNA-US,"DJ Press Release: Melanie Ivarsson, Ph.D. Joins Moderna as Chief Development Officer",DJGM1/30/20,MRNA-US,"Melanie Ivarsson, Ph.D. Joins Moderna as Chief Development Officer",BW1/29/20,MRNA-US,Several Drugmakers are Racing to Create and Test a Vaccine for China's Deadly Coronavirus,PRN1/23/20,MRNA-US,Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus ,BW1/23/20,MRNA-US,DJ Press Release: Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus,DJGM1/12/20,MRNA-US,Moderna Builds on Clinical Validation of Systemic Delivery with Two Additional Development Candidates in New Autoimmune Therapeutic Area ,BW1/12/20,MRNA-US,DJ Press Release: Moderna Builds on Clinical Validation of Systemic Delivery with Two Additional Development Candidates in New Autoimmune Therapeutic Area,DJGM1/12/20,MRNA-US,DJ Press Release: Moderna Builds on Clinical -3-,DJGM1/12/20,MRNA-US,DJ Press Release: Moderna Builds on Clinical -2-,DJGM1/10/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules mRNA-1647 Phase 2 Study Results Call for 10-January-2020 8:00 AM ET",FCSTEV1/9/20,MRNA-US,Moderna Announces Additional Positive Phase 1 Data from Cytomegalovirus (CMV) Vaccine (mRNA-1647) and First Participant Dosed in Phase 2 Study,BW1/9/20,MRNA-US,DJ Press Release: Moderna Announces Additional -2-,DJGM1/9/20,MRNA-US,DJ Press Release: Moderna Announces Additional Positive Phase 1 Data from Cytomegalovirus (CMV) Vaccine (mRNA-1647) and First Participant Dosed in Phase 2 Study,DJGM1/6/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules JP Morgan Health Care Conference - Q&A for 13-January-2020 8:00 PM ET",FCSTEV1/6/20,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules JP Morgan Health Care Conference for 13-January-2020 7:30 PM ET",FCSTEV1/6/20,MRNA-US,DJ Press Release: Moderna to Provide Business and Pipeline Updates at the 2020 J.P. Morgan Healthcare Conference,DJGM1/6/20,MRNA-US,Moderna to Provide Business and Pipeline Updates at the 2020 J.P. Morgan Healthcare Conference,BW12/23/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Investor Meeting - Vaccines Day for 14-April-2020 8:00 AM ET",FCSTEV12/23/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules R&D Day for 17-September-2020 8:00 AM ET",FCSTEV12/23/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Investor Meeting - Manufacturing & Digital Day for 4-March-2020 1:00 PM ET",FCSTEV12/23/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Investor Meeting - Science Day for 2-June-2020 8:00 AM ET",FCSTEV12/19/19,MRNA-US,DJ Press Release: Flagship Unveils Newest Pioneering Platform: Ring Therapeutics,DJGM12/11/19,MRNA-US,DJ Press Release: Moderna Announces Key 2020 Investor and Analyst Events,DJGM12/11/19,MRNA-US,Moderna Announces Key 2020 Investor and Analyst Events,BW12/10/19,MRNA-US,"DJ Press Release: François Nader, M.D., Joins Moderna's Board of Directors",DJGM12/10/19,MRNA-US,"François Nader, M.D., Joins Moderna's Board of Directors",BW11/26/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Piper Jaffray Healthcare Conference for 3-December-2019 9:00 AM ET",FCSTEV11/26/19,MRNA-US,DJ Press Release: Moderna to Present at 31st Annual Piper Jaffray Healthcare Conference,DJGM11/26/19,MRNA-US,Moderna to Present at 31st Annual Piper Jaffray Healthcare Conference ,BW11/6/19,MRNA-US,DJ Press Release: Moderna Provides Business Updates and Reports Third Quarter 2019 Financial Results,DJGM11/6/19,MRNA-US,DJ Press Release: Moderna Provides Business Updates -3-,DJGM11/6/19,MRNA-US,DJ Press Release: Moderna Provides Business Updates -2-,DJGM11/6/19,MRNA-US,Moderna Provides Business Updates and Reports Third Quarter 2019 Financial Results,BW11/5/19,MRNA-US,DJ Press Release: Moderna to Present at Credit Suisse 28th Annual Healthcare Conference,DJGM11/5/19,MRNA-US,Moderna to Present at Credit Suisse 28th Annual Healthcare Conference,BW10/24/19,MRNA-US,Moderna Named Top Employer by Science for Fifth Consecutive Year,BW10/24/19,MRNA-US,DJ Press Release: Moderna Named Top Employer by Science for Fifth Consecutive Year,DJGM10/22/19,MRNA-US,DJ Press Release: Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927),DJGM10/22/19,MRNA-US,Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927),BW10/22/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q3 2019 Earnings Release for 6-November-2019 7:00 AM ET",FCSTEV10/22/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q3 2019 Earnings Call for 6-November-2019 8:00 AM ET",FCSTEV10/22/19,MRNA-US,"DJ Press Release: Moderna to Report Third Quarter 2019 Financial Results on Wednesday, November 6th, 2019",DJGM10/22/19,MRNA-US,"Moderna to Report Third Quarter 2019 Financial Results on Wednesday, November 6th, 2019",BW10/14/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Credit Suisse Healthcare Conference for 13-November-2019 11:45 AM ET",FCSTEV10/5/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules IDWeek Conference - Abstract 2904 for 5-October-2019 4:00 PM ET",FCSTEV10/5/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules IDWeek Conference - Abstract 2754 for 5-October-2019 12:15 PM ET",FCSTEV10/2/19,MRNA-US,Moderna to Present Data From Two of Its Prophylactic mRNA Vaccines at IDWeek 2019,BW9/30/19,MRNA-US,Moderna Announces Open IND for Propionic Acidemia Program (mRNA-3927),BW9/26/19,MRNA-US,Harvard University Establishes mRna Immunotherapy Research Collaboration With Moderna,BW9/26/19,MRNA-US,Moderna Announces mRNA Immunotherapy Research Collaboration with Harvard University,BW9/25/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Chardan Genetic Medicines Conference for 8-October-2019 11:30 AM ET",FCSTEV9/25/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Cantor Global Health Care Conference for 3-October-2019 10:05 AM ET",FCSTEV9/25/19,MRNA-US,Moderna to Present at Upcoming Investor Conferences ,BW9/12/19,MRNA-US,Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944),BW9/12/19,MRNA-US,Moderna Announces Positive Interim Results from Phase 1 Cytomegalovirus (CMV) Vaccine (mRNA-1647) Study and Progress Toward Phase 2 and Pivotal Trials,BW9/4/19,MRNA-US,Moderna Appoints Tracey Franklin as Chief Human Resources Officer,BW8/29/19,MRNA-US,"Moderna to Host R&D Day on September 12, 2019",BW8/27/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Morgan Stanley Global Health Care Conference for 9-September-2019 4:15 PM ET",FCSTEV8/27/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Wells Fargo Health Care Conference for 4-September-2019 9:40 AM ET",FCSTEV8/27/19,MRNA-US,Moderna to Present at Upcoming Investor Conferences,BW8/19/19,MRNA-US,Moderna Receives FDA Fast Track Designation for Zika Vaccine mRNA-1893,BW8/7/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules IDWeek Conference for 2-October-2019",FCSTEV8/7/19,MRNA-US,Moderna Provides Business Updates and Reports Second Quarter 2019 Financial Results,BW7/24/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q2 2019 Earnings Call for 7-August-2019 8:00 AM ET",FCSTEV7/24/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q2 2019 Earnings Release for 7-August-2019 7:00 AM ET",FCSTEV7/24/19,MRNA-US,"Moderna to Report Second Quarter 2019 Financial Results on Wednesday, August 7th, 2019",BW7/10/19,MRNA-US,Moderna to Present at ROTH RNA Revolution Conference ,BW6/28/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules ROTH Capital Partners RNA Revolution Conference for 17-July-2019",FCSTEV6/18/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules BMO Prescription for Success Healthcare Conference for 25-June-2019 3:20 PM ET",FCSTEV6/18/19,MRNA-US,Moderna to Present at BMO 2019 Prescriptions for Success Healthcare Conference,BW6/7/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Goldman Sachs Global Health Care Conference for 12-June-2019 5:00 PM ET",FCSTEV6/7/19,MRNA-US,Moderna to Present at Goldman Sachs 40th Annual Global Healthcare Conference,BW6/2/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules American Society of Clinical Oncology Meeting for 3-June-2019 8:00 AM ET",FCSTEV6/1/19,MRNA-US,Moderna Announces Presentation of Interim Data from Phase 1 Study of mRNA Personalized Cancer Vaccine at 2019 ASCO Annual Meeting,BW6/1/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules American Society of Clinical Oncology Meeting - Abstract 2523 for 1-June-2019 9:00 AM ET",FCSTEV5/17/19,MRNA-US,Moderna Announces Publication of Preclinical Data for Chikungunya Antibody Program,BW5/16/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Annual General Meeting for 27-June-2019 8:00 AM ET",FCSTEV5/10/19,MRNA-US,Moderna Announces Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains,BW5/8/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules American Society of Clinical Oncology Meeting - Poster for 1-June-2019 2:15 PM ET",FCSTEV5/8/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules American Society of Clinical Oncology Meeting - Abstract 2643 for 1-June-2019 9:00 AM ET",FCSTEV5/8/19,MRNA-US,Moderna Reports First Quarter 2019 Financial Results and Provides Business Updates,BW5/6/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Bank of America Merrill Lynch Health Care Conference for 14-May-2019 12:20 PM ET",FCSTEV5/6/19,MRNA-US,Moderna to Present at Bank of America Merrill Lynch 2019 Health Care Conference,BW4/29/19,MRNA-US,Moderna to Present Preclinical Data at 2019 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting,BW4/16/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q1 2019 Earnings Call for 8-May-2019 8:00 AM ET",FCSTEV4/16/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q1 2019 Earnings Release for 8-May-2019 7:00 AM ET",FCSTEV4/16/19,MRNA-US,"Moderna to Host Science Day on May 7, 2019 and Report First Quarter Financial Results on May 8, 2019",BW4/3/19,MRNA-US,Moderna to Present at 18th Annual Needham Healthcare Conference,BW3/18/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Oppenheimer Health Care Conference for 19-March-2019 8:35 AM ET",FCSTEV3/6/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Investor Day for 7-May-2019 9:00 AM ET",FCSTEV3/6/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules R&D Day for 12-September-2019 8:30 AM ET",FCSTEV3/6/19,MRNA-US,Moderna Reports 2018 Fourth Quarter and Full Year Financial Results and Highlights Recent Pipeline Progress,BW3/4/19,MRNA-US,Moderna to Present at Upcoming Investor Conferences in March,BW2/21/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q4 2018 Earnings Release for 6-March-2019 7:00 AM ET",FCSTEV2/21/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules Q4 2018 Earnings Call for 6-March-2019 8:00 AM ET",FCSTEV2/21/19,MRNA-US,"Moderna to Report Fourth Quarter and Full Year 2018 Financial Results on Wednesday, March 6, 2019",BW2/20/19,MRNA-US,Phase 1 Data Published in Nature Communications Show Potential of mRNA Encoding VEGF-A as a Regenerative Therapeutic,BW2/12/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules mRNA-1653 Phase 1 Study Results Call for 12-February-2019 5:00 PM ET",FCSTEV2/12/19,MRNA-US,Moderna Announces Positive Interim Phase 1 Data for First Combination Vaccine Against the Respiratory Viruses hMPV and PIV3,BW2/5/19,MRNA-US,Moderna Announces Dosing of the First Monoclonal Antibody Encoded by mRNA in a Clinical Trial,BW1/30/19,MRNA-US,Newly Published Pre-Clinical Data Show Intratumoral Injections of Messenger RNA Encoding Three Immune Modulators Stimulate Durable Anti-Cancer Responses in Treated and Distal Tumors,BW1/18/19,MRNA-US,Dr. John Mendlein to Transition to an Advisory Role at Moderna and Join Flagship Pioneering as an Executive Partner,BW1/8/19,MRNA-US,Moderna Announces Recent Progress in Its Immuno-Oncology and Rare Disease Programs and Highlights Corporate Objectives,BW1/2/19,MRNA-US,"Moderna, Inc.(MRNA-US) Schedules J.P. Morgan Healthcare Conference for 8-January-2019 1:30 PM ET",FCSTEV1/2/19,MRNA-US,Moderna to Provide Business and Pipeline Updates at the 2019 J.P. Morgan Healthcare Conference,BW12/7/18,MRNA-US,"Nasdaq Welcomes Moderna, Inc. (Nasdaq: MRNA) to The Nasdaq Stock Market",PMZ12/6/18,MRNA-US,Moderna Announces Pricing of Initial Public Offering,BW